Evidence map›Paper›PMID 36795975›Full record

SynthesisRevista medica del Instituto Mexicano del Seguro Social2022

[Bibliometric analysis of scientific publications on COVID-19 elaborated by staff of the Instituto Mexicano del Seguro Social].

Miguel Ángel Villasis-Keever, Alberto Escamilla-Núñez, Carlos Alberto Durán-Muñoz, Heladia García, David Rojano-Mejía, María Guadalupe Miranda-Novales

Abstract readEnglish AbstractSystematic Review
In one paragraph

Synthesis in Revista medica del Instituto Mexicano del Seguro Social, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Miguel Ángel Villasis-KeeverInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Unidad de Investigación en Análisis y Síntesis de la Evidencia. Ciudad de México, México.ORCID 0000-0002-8566-0811
Alberto Escamilla-NúñezInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Unidad de Investigación en Análisis y Síntesis de la Evidencia. Ciudad de México, México.ORCID 0000-0002-5629-7996
Carlos Alberto Durán-MuñozInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Desarrollo de la Investigación. Ciudad de México, México.ORCID 0000-0002-0131-6272
Heladia GarcíaInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Unidad de Investigación en Análisis y Síntesis de la Evidencia. Ciudad de México, México.ORCID 0000-0003-0044-1095
David Rojano-MejíaInstituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, División de Desarrollo de la Investigación. Ciudad de México, México.ORCID 0000-0002-6340-8463
María Guadalupe Miranda-NovalesInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Unidad de Investigación en Análisis y Síntesis de la Evidencia. Ciudad de México, México.ORCID 0000-0003-3262-2608

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Since the beginning of the pandemic, new knowledge about COVID-19 obtained by research has been disseminated in medical and scientific journals, but the large number of publications that have been generated in such a short time has been impressive. Objective: To perform a bibliometric analysis of the published articles in medical-scientific journals carried-out by the Mexican Social Security Institute (IMSS) personnel on COVID-19. Material and methods: Systematic review of the literature, identifying the publications included in the PubMed and EMBASE databases, up to September 2022. Articles on COVID-19 were included, in which at least one author had IMSS affiliation; there was no restriction on the type of publication, so original articles, review articles, clinical case reports, etc. were included. The analysis was descriptive. Results: 588 abstracts were obtained, of which 533 full length articles met the selection criteria. Most were research articles (48%), followed by review articles. Mainly clinical or epidemiological aspects were addressed. They were published in 232 different journals, with a predominance of foreign journals (91.8%). Around half of the publications were carried out by IMSS personnel together with authors from other institutions, national or foreign. Conclusions: The scientific contributions prepared by IMSS personnel have contributed to understanding clinical, epidemiological and basic aspects of COVID-19, which has had an impact on improving the quality of care for its beneficiaries.

Indexed as

COVID-19Academies and InstitutesBibliometricsHumansMexicoSocial SecurityBibliometricsCoronavirus InfectionsInformation ManagementPublications

Identifiers

PMID36795975
PMCPMC10651309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.